Jayasree K. Iyer and Marijn Verhoef to present AMR Benchmark findings in Basel
On March 7, Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, and Marijn Verhoef, Company Engagement Manager, will meet with the Manufacturing Work Group of the AMR Industry Alliance in Basel to discuss how pharmaceutical companies are addressing the rise of drug resistance. The goal of the meeting is to bring together key stakeholders from the industry to exchange information about pharmaceutical company action on AMR, the expectations and opportunities to make change and curb drug resistance.
Jayasree and Marijn will present the key findings of the Antimicrobial Resistance Benchmark with a focus on antibiotic manufacturing and environmental risk-management strategies for slowing AMR. The AMR Benchmark includes detailed analyses of companies’ performances in three areas of corporate activity: R&D for new antimicrobials, policies for ensuring responsible antibiotic manufacturing, and approaches to ensuring antimicrobials are accessible and being used wisely. It aims to guide and incentivise pharmaceutical companies to adopt and implement effective actions for tackling the problem of AMR. The Benchmark has been developed through collaboration with experts and specialists across the spectrum of organisations working to curb AMR.